Phytochemical Name : Sphagneticola trilobata extract

Properties Information
PhytoCAT-ID PhytoCAT-36
Phytochemical name or plant extracts Sphagneticola trilobata extract
PMID 34345598
Literature evidence This study aims to investigate the potential of bioactive secondary metabolites contained in Sphagneticola trilobata (L.) J.F Pruski leaves as novel plant-derived anticancer agent.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Methanolic extract
Source of phytochemicals or plant Extracts Sphagneticola trilobata
Geographical availability Belize, Bolivia, Brazil North, Brazil Northeast, Brazil South, Brazil Southeast, Central American Pac, Colombia, Costa Rica, Ecuador, French Guiana, Guatemala, Guyana, Honduras, Mexico Gulf, Mexico Northwest, Mexico Southeast, Mexico Southwest, Nicaragua, Panamá, Peru, Suriname, Trinidad-Tobago, Venezuela
Plant parts Leaves
Other cancers Breast cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways NA
IC50 Antioxidant activity - 124.34 μg/ml
Potency In vitro MTT assay showed that our extract successfully reached 96% mortality with LC50 = 189.287 μg/mL, where the selective index of 2.5 suggest its selectivity against MCF-7 breast cancer cell line. In conclusion, the data of biological activities suggest the potential development of methanolic extract from S. trilobata leaves as a phytomedicine for breast cancer treatment.
Cell line/ mice model MCF-7
Additional information  The inhibition zone values against E. coli and S. thypi (at extract concentration of 100 mg/mL) were 34.33 and 36 mm, respectively. Previously, we have investigated the ethyl acetate extract from S. trilobata leaves yielding 78.80% apoptosis percentage against MCF-7 breast cancer cell.
PubChem ID NA
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:1093589-2
Safety Based on the cytotoxicity studies, the LC50 value for MCF-7 was lower (189. 287 μg/mL than the Vero cells 465.357 μg/mL).